ASH DLBCL   |  December 18, 2019   Samantha Jaglowski, MD, MPH, Discusses Implications of Tisagenlecleucel for Patients with DLBCL Samantha Jaglowski, MD, MPH, discussed the implications of her analysis of the CAR T-cell therapy tisagenlecleucel in adult patients with relapsed or refractory diffuse large B-cell lymphoma using the Center for International Blood and Marrow Transplant Research database. Read more   ADVERTISEMENT   Lori Leslie, MD, Discusses CAR T-cell therapy and DLBCL Lori Leslie, MD, of the John Theurer Cancer Center, sat down to discuss the relationship between chimeric antigen receptor T-cell therapy and diffuse large B cell lymphoma. Read more